Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2010
08/17/2010US7776334 administering hematopoietic cells to increase blood platelet; for patient receiving cancer chemotherapy or radiation therapy, or immunosuppressants; treating blood disorders anemia, myeloma, non-Hodgkin's lymphoma, Hodgkins lymphoma and leukaemia
08/17/2010US7776332 infant formula which includes casein protein and whey protein; malnutrition; free of arginine and histidine; has an amino acid profile which is close to that of human milk
08/17/2010US7776327 Formulations that interact with and alter expression of epithelial cell tyrosine kinase
08/17/2010US7776326 Methods and compositions for treating neuropathies
08/17/2010US7776325 Bactericide against Streptococcus mutans and Streptococcus sobrinus
08/17/2010US7776320 Methods for therapeutic use of brain derived neurotrophic factor in the entorhinal cortex
08/17/2010US7776311 D-amino acid peptides
08/17/2010US7776240 Injectable hydrogel microspheres from aqueous two-phase system
08/17/2010US7776100 Device for regeneration of articular cartilage and other tissue
08/17/2010US7776026 Method for vitreous liquefaction
08/17/2010US7775469 treatment of conditions characterized by a need to modulate migratory-cell movement associated with specific sites in a subject; isolating a stromal-cell-derived fugetactic agent
08/17/2010CA2547591C Novel compounds and compositions as cathepsin inhibitors
08/17/2010CA2471762C Cell-permeable peptide inhibitors of the jnk signal transduction pathway
08/17/2010CA2444980C Single dose aromatase inhibitor for treating infertility
08/17/2010CA2427227C Lactam compound
08/17/2010CA2412854C Vitronectin receptor antagonist pharmaceuticals for use in combination therapy
08/17/2010CA2411436C A method for detecting protein inhibitors and ligands
08/17/2010CA2370412C Pharmaceutical compounds
08/17/2010CA2284665C Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors
08/17/2010CA2269634C Reagents and methods useful for detecting diseases of the breast
08/17/2010CA2224153C Radiolabeled peptide compositions for site-specific targeting
08/17/2010CA2222679C Separating unmodified hemoglobin from cross-linked hemoglobin
08/17/2010CA2169260C Gene therapy for solid tumors, papillomas and warts
08/13/2010CA2654108A1 Methods for treating septic shock
08/12/2010WO2010091373A2 Trimeric hiv fusion inhibitors for treating or preventing hiv infection
08/12/2010WO2010090876A2 Satiation peptide administration
08/12/2010WO2010090758A2 Diabetes diagnostic, prophylactic, and therapeutic compositions and methods
08/12/2010WO2010090744A1 Methods and compositions for treating neuropathies
08/12/2010WO2010090677A1 Clostridial toxin pharmaceutical compositions
08/12/2010WO2010090523A1 Truncated cystine-knot proteins
08/12/2010WO2010090222A1 Hb-egf-bound protein complex
08/12/2010WO2010089706A1 Use of igf-1 and nt-3 in the treatment of x-linked adrenoleukodystrophy
08/12/2010WO2010089672A1 Glp-1 analogues pharmaceutical compositions
08/12/2010WO2010089554A1 Peptides for vaccine
08/12/2010WO2010089544A1 Actagardine derivatives
08/12/2010WO2010089522A1 Stable formulation of a therapeutic protein
08/12/2010WO2010089442A1 Method for treating neurodegenerative diseases
08/12/2010WO2010089379A1 Method and means for producing tissues and tissues obtained
08/12/2010WO2010089341A1 Novel vancomycin-aminoquinoline hybrid molecules their preparation and their application in therapeutics
08/12/2010WO2010089129A1 Inhibitors of viral fusion and uses thereof
08/12/2010WO2010089122A2 Vector(s) containing an inducible gene encoding a cdk4/cdk6 inhibitor useful for treating neurodegenerative disorders or diseases associated with an unscheduled activation of the cell cycle
08/12/2010WO2010089120A1 Novel method for the manufacturing of neurotoxins
08/12/2010WO2010089064A1 Use of specific peptides in the preparation of a medicament for the treatment of monoclonal gammopathy of undetermined significance (mgus) or of smoldering multiple myeloma (smm)
08/12/2010WO2010088803A1 New porcine reproductive and respiratory syndrome virus receptor, and blockers thereof
08/12/2010WO2010088778A1 Cd109 polypeptides and uses thereof for the treatment of skin cells
08/12/2010WO2010088729A1 Compositions and uses therefor
08/12/2010WO2010069570A3 Peptides against autoantibodies associated with crps and use of these peptides
08/12/2010WO2010069090A3 Pharmaceutical composition containing angiotensin-(1-9) for cardiovascular, pulmonary and/or cerebral treatment
08/12/2010WO2010062399A3 Csf1r extracellular domain fusion molecules and treatments using same
08/12/2010WO2010054102A3 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof
08/12/2010WO2010042868A3 Methods for treating obesity
08/12/2010WO2010019954A9 Purine nucleoside phosphorylase as enzymatic activator of nucleoside prodrugs
08/12/2010WO2010019263A3 Soluble flt constructs for treating cancers
08/12/2010WO2010019257A3 Prodrug activation in cancer cells using molecular switches
08/12/2010WO2010013012A9 Hypothermia inducing polypeptides and uses thereof
08/12/2010WO2009143367A3 Egf-a domain-mediated modulation of pcsk9 for treating lipid disorders
08/12/2010WO2009130600A8 Therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy
08/12/2010WO2009036338A3 Methods for addressing ocular diseases through interference with the wnt signaling pathway
08/12/2010US20100204673 Obesity controlling method
08/12/2010US20100204458 Process for the Production of Immunogenic Compositions
08/12/2010US20100204453 Antibodies to tumor associated proteins
08/12/2010US20100204447 Use of anitmicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
08/12/2010US20100204308 Cell proliferation inhibitory proteins and polynucleotides, antisense polynucleotides to the polynucleotides, cell proliferation inhibitors using the foregoing, cancer diagnostic agents, cancer therapeutic agents and compositions for gene therapy
08/12/2010US20100204304 NOGO Receptor Binding Protein
08/12/2010US20100204297 Influenza therapeutic
08/12/2010US20100204160 Substituted 1,2-ethylenediamines, methods for preparing them and uses thereof
08/12/2010US20100204159 Organic compounds and their uses
08/12/2010US20100204158 Combination of splenopentin and thymopentin and the use thereof in medicine
08/12/2010US20100204157 Use of a peptide as a therapeutic agent
08/12/2010US20100204156 Use of thymopentin as a therapeutic agent
08/12/2010US20100204155 Use of the peptide sfllr-oh and muramyl dipeptide as therapeutic agents
08/12/2010US20100204154 Use of the peptide rfmwmr as a therapeutic agent
08/12/2010US20100204153 Use of band 3 protein (824-829) and/or melanocyte-stimulating hormone release-inhibiting factor as a therapeutic agent in the treatment of pseudomonas aeruginosa infection
08/12/2010US20100204152 Use of gluten exorphin c : as a therapeutic agent
08/12/2010US20100204151 Use of a peptide as a therapeutic agent
08/12/2010US20100204150 Use of a peptide as a therapeutic agent
08/12/2010US20100204149 Use of octreotide as a therapeutic agent
08/12/2010US20100204148 (d-leu7 ) -histrelin as a therapeutic agent
08/12/2010US20100204147 Methods For Delivering Thymosin Beta 4, Analogues, Isoforms and Other Derivatives
08/12/2010US20100204146 Treatment of Oestrogen Dependant Conditions in Pre-menopausal Women
08/12/2010US20100204145 Use of a peptide as a therapeutic agent
08/12/2010US20100204144 Use of the peptides maippkknqdk (cow kappa casein 106-116) and/or ygfqna (serorphin) as therapeutic agents
08/12/2010US20100204143 Gamma 1 msh alone or in combination with pentagastrin as a therapeutic agent
08/12/2010US20100204142 Use of the peptide phpfhlfvy (renin inhibitor) as a therapeutic agent
08/12/2010US20100204141 Use of bpp-b as a therapeutic agent
08/12/2010US20100204140 Use of a peptide as a therapeutic agent
08/12/2010US20100204139 Use of gonadorelin as a therapeutic agent
08/12/2010US20100204138 Use of trp6-triptorelin and d-leu6-leuprolide as therapeutic agents
08/12/2010US20100204137 The use of substances for the treatment of loss of eyesight in humans with glaucoma and other degenerative eye diseases
08/12/2010US20100204136 Use of a peptide as a therapeutic agent
08/12/2010US20100204135 Use of lvv-hemorphin-6 and optionally af12198 as therapeutic agent(s)
08/12/2010US20100204134 Use of the peptide his-ser-leu-gly-lys-trp-leu-gly-his-pro-asp-lys-phe alone or in combination with the peptide gly-ard-gly-asp-asn-pro-oh as a therapeutic agent
08/12/2010US20100204133 Irreversibly-inactivated pepsinogen fragment and pharmaceutical compositions comprising the same for detecting, preventing and treating HIV
08/12/2010US20100204132 THERAPEUTIC USES OF PEPTIDES YSAYPDSVPMMS and WMNSTGFTKVCGAPPC
08/12/2010US20100204131 Use of a peptide as a therapeutic agent
08/12/2010US20100204130 Use of human neuropeptide as a therapeutic agent
08/12/2010US20100204129 Use of a peptide as a therapeutic agent
08/12/2010US20100204128 Novel peptides
08/12/2010US20100204127 Use of a botulinum neurotoxin to alleviate various disorders
08/12/2010US20100204126 Therapy for melanin related afflictions
1 ... 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 ... 3163